| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/08/2002 | WO2002038541A9 Cyanopyrrolidine derivatives |
| 08/08/2002 | WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | WO2000074736A9 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| 08/08/2002 | US20020107396 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-N-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide. |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107285 Novel compounds to treat diabetes and associated conditions |
| 08/08/2002 | US20020107278 Substituted azepino[4,5b]indole derivatives |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107249 Administering a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine of at least about 5000, such as reboxetine; treating and prophylaxis of various psychological and neurological disorders |
| 08/08/2002 | US20020107242 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107236 Methods of treating sexual dysfunction associated with hypertension |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | US20020107233 Useful for treating hypocholesterolemia |
| 08/08/2002 | US20020107210 Compositions and methods for the treatment of autoimmune diabetes |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020107175 Insulin c-peptides |
| 08/08/2002 | US20020106762 Generating preerential compound for use as prophylactic agent; obtain chemical intermediate, incubate with enzyme, recover prophylactic agent |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106713 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/08/2002 | US20020106703 Screening cell pool for pancreatic progenitor cells; obtain mammalian cell culture, incubate with marker protein, detect those cells bound by marker protein |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106368 Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same |
| 08/08/2002 | US20020106358 Synthetic mammalian sulphamidase and genetic sequences encoding same |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436576A1 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436425A1 Hypoglycemic agent |
| 08/08/2002 | CA2436418A1 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436397A1 Method of treating certain eye diseases |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2434853A1 Chemical compounds |
| 08/08/2002 | CA2434495A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2430878A1 Anticholesterolemic edible oil |
| 08/08/2002 | CA2429969A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1229026A1 Alkoxyiminoalkanoic acid derivatives |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228761A2 Liquid pharmaceutical composition for treating bone diseases |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228705A2 Process to produce dry powder of a carotenoid or several carotenoids |
| 08/07/2002 | EP1228698A1 Sorbic acid as growth-stabilising feed additive in animal raising |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227824A1 Transplant/implant device and method for its production |
| 08/07/2002 | EP1227816A1 Cholesterol lowering and blood lipids lowering composition |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227803A2 Methods and compounds for inhibiting amyloid deposits |
| 08/07/2002 | EP1227791A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |